La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Receptors, Dopamine D1 (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Receptors, Dopamine D1 (antagonists & inhibitors) < Receptors, Dopamine D1 (drug effects) < Receptors, Dopamine D1 (genetics)  Facettes :

List of bibliographic references indexed by Receptors, Dopamine D1 (drug effects)

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
002988 (2005) Michel St-Hilaire [Canada] ; Eric Landry ; Daniel Lévesque ; Claude RouillardDenervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
003562 (2000) M. Goulet [Canada] ; R. Grondin [Canada] ; M. Morissette [Canada] ; S. Maltais [Canada] ; P. Falardeau [Canada] ; P. J. Bedard [Canada] ; T. Di Paolo [Canada]Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-Monkeys
003E56 (1996) P. J. Blanchet [Canada] ; R. Grondin [Canada] ; R. Bédard [Canada]Dyskinesia and wearing‐off following dopamine D1 agonist treatment in drug‐naive 1‐Methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐lesioned primates
004315 (1993) P. Seeman [Canada] ; H H Van TolDopamine receptor pharmacology.
004437 (1993) P. J. Bedard ; B. Gomez-Mancilla ; P. Blanchette ; C. Gagnon [Canada] ; P. Falardeau [Canada] ; T. Dipaolo [Canada]Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys
004453 (1993) B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. BedardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
004454 (1993) P. Blanchet [Canada] ; P. J. Bedard [Canada] ; D. R. Britton ; J. W. KebabianDifferential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-exposed monkeys
004459 (1993) C. Gagnon [Canada] ; B. Gomez-Mancilla ; P. J. Bedard ; T. Di Paolo [Canada]Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Receptors, Dopamine D1 (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Receptors, Dopamine D1 (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Receptors, Dopamine D1 (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022